ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1133

Genetic Variants Influencing Joint Damage in Mexican Americans and European Americans with Rheumatoid Arthritis

Rector Arya1, del Rincon Inmaculada2, Vidya S Farook3, Jose Felix Restrepo4, Deidre A Winnier5, Marcel J Fourcaudot2, Daniel Battafarano6, Satish Kumar7, Marcio AA de Almeida3, Joanne E Curran7, Christopher P Jenkinson5, John Blangero3, Ravindranath Duggirala7 and Agustin Escalante4,8,9, 1Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Genetics, Texas Biomedical Research Institute, San Antonio, TX, 4Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 5University of Texas Health Science Center at San Antonio, San Antonio, TX, 6Rheumatology, San Antonio Military Medical Center, JBSA - Ft Sam Houston, TX, 7Texas Biomedical Research Institute, San Antonio, TX, 8Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 9Dept. of Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: genetics, Hispanic patients, joint damage and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics, Genomics and Proteomics II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Joint damage in rheumatoid arthritis (RA) has been shown to be heritable, but knowledge on specific genetic determinants of joint damage in RA is limited. We have used the ImmunoChip array to examine whether genetic variants with relevance to susceptibility to multiple autoimmune diseases including RA, influence variation in joint damage in Mexican Americans (MA) and European Americans (EA) with RA.

Methods: We recruited 720 MA and 424 EA patients with RA from public, private, military and VA rheumatology clinics. Joint damage was quantified using a radiograph of both hands and wrists, scored for erosions and joint-space narrowing using Sharp’s technique. The Sharp scores were transformed using inverse normalization to approximate a normal distribution for the subsequent association analyses. To identify ethnic outliers, principal components (PCs) were derived using EIGENSTRAT principal component analysis. We conducted association analyses with the transformed Sharp score as a quantitative trait and single nucleotide polymorphism (SNP) genotypic (i.e., autosomal SNPs) data obtained from the Immunochip in both MA and EA samples using the program PLINK. We used the linear regression additive genetic model which included covariates age, sex, and the first two principal components (PC1 and PC2) to adjust for potential population stratification influences.

Results: After excluding SNPs due to the following reasons: stringent quality control, admixture and cryptic relationship inference analyses, and SNPs with minor allele frequency below 1%, our Sharp score association analyses involved 127,563 and 128,387 autosomal SNPs in MA and EA, respectively. Both phenotypic and genotypic data were available for 666 MAs and 407 EAs. In MAs, the 15 SNPs with the strongest association with joint damage were located in chromosomes 1, 5, 9, 17 and 22 with p-values ranging from p < 1 x 10-5 to p ≤ 1 x 10-6 including the best associated SNP rs7216796 (β ± SE = -0.25 ± 0.05, p = 6.23 x10-6 within the MAP3K14 gene on chromosome 17. In EAs, there were 28 SNPs from chromosomes 1, 4, 6, 9, and 21 with strong p-values ranging from p < 1 x 10-5 to p ≤ 1 x 10-6, showing associations with joint damage. The best associated SNP was rs59902911 (β ± SE = 0.86 ± 0.17, p = 1.01 x 10-6) in the CARD9 gene on chromosome 9. Aside from the above population-specific association signals, we also found evidence for several loci influencing joint damage in both MAs and EAs. However, none of the association signals found in our study reached the Bonferroni-adjusted significance level. 

Conclusion: We identified novel loci that influence variation in joint damage on chromosomes 17 (MAP3K14) and 9 (CARD9) strongly associated with joint damage in MAs and EAs with RA, respectively. We also found several ethnic-specific and shared loci showing suggestive associations with joint damage in MAs and EAs. These novel findings, observed in MAs and EAs, may provide new insights into the genetic architecture of joint damage in RA.


Disclosure:

R. Arya,
None;

D. R. Inmaculada,
None;

V. S. Farook,
None;

J. F. Restrepo,
None;

D. A. Winnier,
None;

M. J. Fourcaudot,
None;

D. Battafarano,
None;

S. Kumar,
None;

M. A. de Almeida,
None;

J. E. Curran,
None;

C. P. Jenkinson,
None;

J. Blangero,
None;

R. Duggirala,
None;

A. Escalante,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetic-variants-influencing-joint-damage-in-mexican-americans-and-european-americans-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology